Laboratory News and Research

RSS

CINJ receives $75,000 grant from Breast Cancer Alliance

For the second consecutive year, The Cancer Institute of New Jersey has been awarded a $75,000 grant from the non-profit entity the Breast Cancer Alliance. The grant, which supports the institute's Breast Surgery Fellowship Program, is for academic year 2013-2014.

29 Jan 2013

NSAIDs pose kidney risk in some children

A small but significant percentage of children develop acute kidney injury after taking nonsteroidal anti-inflammatory drugs such as ibuprofen, show study findings published in the Journal of Pediatrics.

29 Jan 2013

Have scientists thoroughly addressed avian flu research concerns?

Noting that a nearly yearlong moratorium on H5N1 avian influenza research, put in place "because of safety and terrorism concerns," was lifted recently, a New York Times editorial states, "We wish we could be as sanguine as they are that all the earlier concerns have been dealt with."

29 Jan 2013

Colorectal cancer screening: an interview with Dr Donato F. Altomare

Colorectal cancer is a malignant neoplasm affecting the large bowel and the rectum mainly after the 5th decade of life and representing the second cause of death for cancer in western countries (the third in women). In about 15-20% of patients there is an inherited predisposition.

29 Jan 2013

Study examines how fear responses are learned, controlled and memorized

A rustle of undergrowth in the outback: it's a sound that might make an animal or person stop sharply and be still, in the anticipation of a predator. That "freezing" is part of the fear response, a reaction to a stimulus in the environment and part of the brain's determination of whether to be afraid of it.

29 Jan 2013

New genetic test can help identify small aggressive lung tumors linked with poor survival

A novel genetic test can help identify small but aggressive lung tumors associated with poor survival, according to a study released today at the 49th Annual Meeting of The Society of Thoracic Surgeons held at the Los Angeles Convention Center.

29 Jan 2013

Coming out of the closet helps reduce depressive symptoms and allostatic load levels in LGBs

Lesbians, gays and bisexuals (LGBs) who are out to others have lower stress hormone levels and fewer symptoms of anxiety, depression, and burnout, according to researchers at the Centre for Studies on Human Stress (CSHS) at Louis H. Lafontaine Hospital, affiliated with the University of Montreal. Cortisol is a stress hormone in our body. When chronically strained, cortisol contributes to the 'wear and tear' exerted on multiple biological systems. Taken together, this strain is called "allostatic load".

29 Jan 2013

Skin cells transformed into heart cells for research into cardiomyopathy

...

28 Jan 2013

Researchers investigate acidity in solid tumors to determine if pH levels play a role in cell invasion

Researchers at Moffitt Cancer Center and colleagues at Wayne State University School of Medicine investigated the acidity in solid tumors to determine if pH levels play a role in cancer cell invasion in surrounding tissues.

28 Jan 2013

LOX enzyme can create scarred microenvironment that enhances cancer spreading

What to fear most if faced by a cancer diagnosis is the spread of the cancer to other parts of the body. This process called metastasis accounts for over 90% of cancer patient deaths and therefore is a strong focus for cancer researchers.

28 Jan 2013

Counsyl, ARUP partner to expand pregnancy genetic test offering for prospective parents

Counsyl has partnered with ARUP Laboratories, a nonprofit enterprise of the University of Utah, to expand its pre-pregnancy and early pregnancy genetic test offering for prospective parents. ARUP's molecular genetic testing laboratory already provides a comprehensive set of testing options for a broad range of inherited disorders.

28 Jan 2013

HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

The U. S. Patent and Trademark Office recently issued a patent to the U. S. Department of Health and Human Services involving resiniferatoxin, or RTX, an experimental compound that represents a potential new class of drugs to alleviate the intractable pain that can occur in people with advanced cancer, severe arthritis, and other extremely chronic conditions.

28 Jan 2013

UMDNJ-School of Osteopathic Medicine to develop blood test that can diagnose MCI

The Biomarker Discovery Center at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine has been awarded a three-year, $799,800 grant from the Osteopathic Heritage Foundation to develop a blood test that can diagnose mild cognitive impairment (MCI) caused by early-stage Alzheimer's disease.

28 Jan 2013

Gilead commences first of two tenofovir alafenamide Phase 3 trials in HIV

Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.

28 Jan 2013

Leading-edge Masimo medical devices to be displayed at Arab Health

Masimo returns to Arab Health Jan. 28-31, the world's longest running healthcare exhibition and congress held each year in Dubai, UAE, to showcase advanced, noninvasive patient monitoring technologies – including breakthrough SET Measure-Through Motion pulse oximetry and rainbow Pulse CO-Oximetry – that are becoming the standard-of-care across the Middle East.

28 Jan 2013

Reducing the level of mutant p53 gene increases susceptibility to cancer treatment

Scientists from the National Cancer Centre Singapore (NCCS) have discovered the workings of the gene that has been hindering treatment response in cancer patients. This discovery was made after 5 years of studying the mutant form of the p53 gene, the major tumor suppressor in humans, which is generally found mutated in over 50% of all type of human cancers.

27 Jan 2013